North America News
-
North America | News | 0 Comment | 26 Sep, 2024
To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutic...Read more
-
North America | News | 0 Comment | 18 Sep, 2024
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced the commercial release of...Read more
-
MilliporeSigma launches single-use reactor to accelerate antibody drug conjugate manufacturing
North America | News | 0 Comment | 11 Sep, 2024
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the first single...Read more
-
Agilent unveils biopharma CDx services lab to accelerate precision medicine
North America | News | 0 Comment | 10 Sep, 2024
Agilent Technologies Inc., has announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, C...Read more
-
First cloud-based AI endoscopy system for colonoscopy gets US FDA clearance
North America | News | 0 Comment | 06 Sep, 2024
Odin Medical, an Olympus Corporation company, has received US Food and Drug Administration (FDA) 510(k) clearance f...Read more
-
North America | News | 0 Comment | 05 Sep, 2024
Japan-based Astellas Pharma Inc. has officially opened its new Astellas Life Sciences Centre (ALSC) in Ca...Read more
-
Australia's BCAL Diagnostics commences operations in US
North America | News | 0 Comment | 28 Aug, 2024
BCAL Diagnostics, based in Sydney, Australia, has established a subsidiary in the US and will commence operations out of...Read more
-
GE HealthCare to embark on collaboration to elevate imaging for women’s health
North America | News | 0 Comment | 19 Aug, 2024
GE HealthCare has announced a collaboration with the University of California San Diego School of Medicine, in the US, t...Read more
-
ARS Pharma receives US FDA approval for first nasal spray to treat anaphylaxis
North America | News | 0 Comment | 09 Aug, 2024
The US Food and Drug Administration (FDA) has approved neffy (epinephrine nasal spray) for the emergency treatment of al...Read more
-
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids
North America | News | 0 Comment | 07 Aug, 2024
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...Read more
-
Waters announces global release of new Differential Scanning Calorimeter
North America | News | 0 Comment | 24 Jul, 2024
Waters Corporation has announced the global release of the TA Instruments Rapid Screening-Differential Scanning Cal...Read more
-
Japan's Nipro Corp invests $398 M into new medical device manufacturing facility in US
North America | News | 0 Comment | 18 Jul, 2024
Nipro Medical Corporation, a subsidiary of Japan headquartered Nipro Corporation, has announced its significant expansio...Read more
-
North America | News | 0 Comment | 17 Jul, 2024
Donaldson, a global provider of innovative biomanufacturing technologies, with its Univercells Technologies business, an...Read more
-
Thermo Fisher to help advance myeloid cancer clinical research
North America | News | 1 Comment | 12 Jul, 2024
To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), US-...Read more
-
BD commercially launches new single-cell research tool for scientists
North America | News | 0 Comment | 27 Jun, 2024
American firm BD (Becton, Dickinson and Company), a leading global medical technology company, has announced the commerc...Read more
-
Thermo Fisher unveils fully automated plasmid purification system
North America | News | 0 Comment | 26 Jun, 2024
US-based Thermo Fisher Scientific Inc. has introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor, the on...Read more
-
Taiwan's Bora Pharma buys US-based Emergent BioSolutions' manufacturing site for $30 M
North America | News | 0 Comment | 24 Jun, 2024
US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility in Baltimo...Read more
-
US FDA expands approval of gene therapy for patients with Duchenne Muscular Dystrophy
North America | News | 0 Comment | 21 Jun, 2024
The US Food and Drug Administration (FDA) has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a g...Read more
